Researchers at Mayo Clinic announced on May 15, 2026 that synthetic DNA molecules called aptamers can reliably tag senescent "zombie" cells in mouse tissue—a long-sought step that could finally enable drugs to destroy these inflammation-driving cells without harming healthy neighbors.